2009 Site Solutions Summit Attendees Help Further CISCRP’s Cause
Ellicott City, MD, October 22, 2009 – Clinical research professionals, including executives from leading Sponsors, clinical research organizations, and stakeholders from clinical research sites came together at the 4th Annual Site Solutions Summit and raised $5k in just a few short hours for the Center for Information & Study on Clinical Research Participation (CISCRP).
Over 240 attendees gathered for three days at the this year’s Site Solutions Summit, co-hosted by RxTrials Inc. and the Association of Clinical Research Organizations (ACRO), where discussions about the challenges in managing clinical research studies, sites and industry trends were shared and Best Site Practices identified.
At the request of Christine Pierre, founder of the Site Solutions Summit, conference attendees literally reached into their own pockets during the conference for loose $5, $10, $20 and $100 bills to give to CISCRP whose mission is to raise awareness and educate the general public about the process of clinical research. Pierre reminded attendees about the non-profit organizations’ need for industry support and stressed the importance for the clinical research industry to help further the cause. Every dollar raised will help support the communications, education, and public awareness programs at CISCRP.
“As an industry, we recognize how crucial it is for the general public to have a greater understanding of the clinical research process first and then to consider participation in a fully informed manner. Next: CISCRP’s mission. As the leaders of premier clinical research sites and others committed to clinical research it only makes sense that we, the voice of the sites, would support this effort,” said Christine Pierre. “I was humbled by the generous giving after spontaneously requesting those attending the Site Solutions Summit to support the CISCRP mission.”
According to CenterWatch, 94% of people recognize the importance of participating in clinical research in order to assist in the advancement of medical science, yet 75% of the general public state they have little to no knowledge about the clinical research enterprise and the participation process. Education and information about clinical research participation and the important role it plays in public health begins with CISCRP. CISCRP is working to create and promote a greater awareness and understanding about clinical research and how therapies get into the hands of the people who need them the most.
“CISCRP relies on its extensive network of volunteers and supporters,” said Ken Getz, Founder and Chairman of the Center for Information & Study on Clinical Research Participation. “We deeply appreciate the support that we’ve received from the Site Solutions Summit. This donation will help us in our efforts to provide educational materials to patients and the public.”
About RxTrials Inc.
RxTrials is a premiere network of Investigative Sites that conduct Phase II through Phase IV and vaccine clinical research studies in physician practice’s, clinics and hospitals. Since 1994 RxTrials has successfully competed over 1,000 clinical research studies and is a strategic partner with many clinical research organizations and sponsors and also is the co-host of the annual Site Solutions Summit. RxTrials Institute, a sister company of RxTrials, provides training, education and consultation to clinical research professionals and organizations.
Founded in 2003, The Center for Information and Study on Clinical Research Participation (CISCRP) is a first-of-its-kind nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media, and policy makers about clinical research participation and the role that each party plays as a participant in the process. CISCRP’s staff and board of advisors have highly diverse backgrounds – from the clinical research, healthcare and advocacy communities. CISCRP’s funding comes from a wide variety of sources including individual donors, government and research institutions, foundations and corporations.